PT  - JOURNAL ARTICLE
AU  - Javier Cortes-Ramirez
AU  - Juan D. Wilches-Vega
AU  - Ruby N. Michael
AU  - Vishal Singh
AU  - Olga M. Paris-Pineda
TI  - Estimating spatial disease rates from health statistics without geographic identifiers
AID  - 10.1101/2022.04.18.22274002
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.18.22274002
4099  - http://medrxiv.org/content/early/2022/04/19/2022.04.18.22274002.short
4100  - http://medrxiv.org/content/early/2022/04/19/2022.04.18.22274002.full
AB  - Effective analysis to support decision-making in public health requires adequate data that can be linked to the sociodemographic characteristics and distribution of communities that would be recipients of health programs. Although official statistics are an important source of data to support decisions on public health strategies, health statistics are of limited use if they do not include categorisations related to the spatial distribution of the population. This study introduces a method to use the frequency of disease reported by health care providers (HCP) to calculate disease rates in geographical areas in urban settings. Specifically, this study uses statistics on acute respiratory infections (ARI) to calculate the rate of these diseases at the census district level in Cúcuta, a major city in Colombia. A Geographic Information System was used to establish the geographical area of influence (spatial scope) of each HCP, according to the distribution of the basic census geographical areas; the Urban Sections (USEC), in Cúcuta. Three levels of increasing spatial aggregation were established considering the characteristics of the population receiving health care in primary, intermediate and tertiary public health services to establish the spatial scope of each HCP. The cases of ARI per USEC were calculated according to the proportion of the population of each USEC in each of the three levels. The spatial rate of ARI per USEC and the hotspots of higher risk of ARI were calculated using an Empirical Bayes method using a geostatistical software.There were 97 HCP, of which, 31 provided health services in USEC in level 1; 20 provided health services in USEC in level 2; and 47 provided health services in USEC in level 3. A higher spatial rate of ARI was found in USEC in central south; central west; north and northwest; northeast; central east; and central regions, compared to the whole of Cúcuta. Hotspots of higher risk were identified in two clusters of USEC in central south and west Cúcuta and three isolated USEC in central and northwest Cúcuta.Health indicators at the census district geographical level could be calculated using basic statistics that do not include geographic identifiers by considering the characteristics of the HCP and the population receiving their services. The methodology of this study can be applied to other socioeconomic contexts where geographic identifiers are not attached to public health statistics to create better public health indicators and support potential health promotion and disease prevention strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of the University of Santander, record VII-FT-025-UDES, 021 25/06/2019.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the study are available upon reasonable request to the authors. The raw data provided by the Department of Health is subject to their authorisation to be published.